A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients
Crossref DOI link: https://doi.org/10.1186/s40064-015-1603-5
Published Online: 2015-12-22
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Xinna
Yu, Jing
Wang, Wenmiao
Song, Guohong
Wang, Xiaoli
Ren, Jun
Di, Lijun
Wang, Xinghe
License valid from 2015-12-01